AORT · Transaction Oct 9, 2025 · Filed Nov 18, 2025 · $1,001 to $15,000
NEW YORK STOCK EXCHANGE, INC. · AORT
-2.71% · -$0.7300 · Vol 964.0K
After hours · updated 16:44:51 ET
Artivion Inc
Health Care
$26.17
Veridion Score
BETAHIGH CONF · 6/6 factorsStale score · Tue Aug 4 · completed session · 23h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET · AORT
MethodologyAORT
Artivion Inc
Stale score · Tue Aug 4 · completed session · 23h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET
NEUTRAL
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
55/ 100
Veridion Score
NEUTRAL · HIGH confidence
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6/6 factors with data · Stale score · Tue Aug 4 · completed session · 23h old · Scheduled each trading day · Markets closed · resumes Thu 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is AORT moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Artivion Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSListed since
1993
Employees
2K
Country
US
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$26.77
Day high
$27.32
Day low
$25.79
Previous close
$26.90
52W high
$47.63
-45.06% from high
52W low
$20.10
22% of range
Market cap
$1.3B
P/E
145.39×
EPS
$0.1800
Beta
0.09
Shares out
48.5M
Volume
964K
1.36× rel vol
Avg volume
710.3K
VWAP
$26.18
Price history computed in-house
1W
-5.01%
1M
+6.12%
3M
-26.12%
1Y
-18.60%
YTD
-42.62%
SMA 50 $23.34 · above
SMA 200 $35.66 · below
52W position 22%
AORT overview
Veridion Score
55
6 of 6 factors measured
Congress receipts
5
Gilbert Ray Cisneros, Jr. · Sale
13F holders
None on file
Related filings and maps
Public disclosures
Congress activity in AORT
Official filing ↗
Artivion, Inc. Common Stock · Transaction Nov 16, 2023 · Filed Nov 20, 2023 · $50,001 to $100,000
Artivion, Inc. Common Stock · Transaction Nov 10, 2023 · Filed Nov 20, 2023 · $50,001 to $100,000
Artivion, Inc. · Transaction Jul 14, 2023 · Filed Aug 21, 2023 · $1,001 to $15,000
Artivion, Inc. · Transaction Jun 13, 2023 · Filed Jul 11, 2023 · $1,001 to $15,000
Federal contracts
AORT contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for AORT in this window.
Lobbying spend
AORT lobbying filings, year to date.
Registered lobbying filings matched to Artivion Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for AORT in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for AORT.
Options
Sovereign unlock shows live options positioning for AORT.